Carcinogenesis, Vol 19, 1867-1871, Copyright © 1998 by Oxford University Press
EL Crawford, DA Weaver, JP DeMuth, CM Jackson, SA Khuder, MW Frampton, MJ Utell, WG Thilly and JC Willey
Bronchogenic carcinomas arise from bronchial epithelial cells (BECs).
Inhalation exposure of BECs to nitrosamines in cigarette smoke is an
important exogenous risk factor for malignant transformation of BECs. Thus,
an important endogenous risk factor is likely to be the capacity of BECs to
metabolize nitrosamines. Among the cytochrome P450 enzymes capable of
metabolizing nitrosamines, CYP2A6, CYP2E1 and CYP2B6 are expressed in BECs.
In this study, we used quantitative RT-PCR to evaluate expression of CYP2A6
and CYP2E1 in primary human BECs from 12 non-smokers and eight smokers.
CYP2A6 was expressed in 20/20 cases and quantifiable in 18/20 cases, with a
mean level of 580 mRNA/10(6) beta- actin mRNA. CYP2E1 expression was
observed in 9/20 cases, but in all cases it was expressed at levels below
our limit of quantification (10 mRNA/10(6) beta-actin mRNA). There was
significant (P < 0.05) 20-fold inter-individual variation in expression
of CYP2A6. Further, the mean level of CYP2A6 among smokers (260 mRNA/10(6)
beta-actin mRNA) was significantly lower than among non-smokers (740
mRNA/10(6) beta-actin mRNA). It is hypothesized that: (i) inter-individual
variation in CYP2A6 gene expression may contribute to inter-individual
variation in risk for bronchogenic carcinoma; (ii) smoking may reduce the
level of expression of CYP2A6 in the BECs of some individuals; and (iii)
CYP2A6 is more important than CYP2E1 for metabolic activation of
nitrosamines in bronchial epithelial cells.
ARTICLES
Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells
Department of Medicine, Medical College of Ohio, Toledo 43699-0008, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Blomquist, E. L. Crawford, D. Mullins, Y. Yoon, D.-A. Hernandez, S. Khuder, P. L. Ruppel, E. Peters, D. J. Oldfield, B. Austermiller, et al. Pattern of Antioxidant and DNA Repair Gene Expression in Normal Airway Epithelium Associated with Lung Cancer Diagnosis Cancer Res., November 15, 2009; 69(22): 8629 - 8635. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Smith, J. L. Sanders, P. R. Porubsky, G. H. Lushington, C. D. Stout, and E. E. Scott Structure of the Human Lung Cytochrome P450 2A13 J. Biol. Chem., June 8, 2007; 282(23): 17306 - 17313. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyazaki, H. Yamazaki, H. Takeuchi, K. Saoo, M. Yokohira, K.-i. Masumura, T. Nohmi, Y. Funae, K. Imaida, and T. Kamataki Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas Carcinogenesis, November 1, 2005; 26(11): 1947 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hukkanen, P. Jacob III, and N. L. Benowitz Metabolism and Disposition Kinetics of Nicotine Pharmacol. Rev., March 1, 2005; 57(1): 79 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Mastrangelo, U Fedeli, E Fadda, G Milan, A Turato, and S Pavanello Lung cancer risk in workers exposed to poly(vinyl chloride) dust: a nested case-referent study Occup. Environ. Med., June 1, 2003; 60(6): 423 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ariyoshi, M. Miyamoto, Y. Umetsu, H. Kunitoh, H. Dosaka-Akita, Y.-i. Sawamura, J. Yokota, N. Nemoto, K. Sato, and T. Kamataki Genetic Polymorphism of CYP2A6 Gene and Tobacco-induced Lung Cancer Risk in Male Smokers Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 890 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hukkanen, O. Pelkonen, and H. Raunio Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD Eur. Respir. J., July 1, 2001; 18(32_suppl): 122S - 126s. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Su, Z. Bao, Q.-Y. Zhang, T. J. Smith, J.-Y. Hong, and X. Ding Human Cytochrome P450 CYP2A13: Predominant Expression in the Respiratory Tract and Its High Efficiency Metabolic Activation of a Tobacco-specific Carcinogen, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Cancer Res., September 1, 2000; 60(18): 5074 - 5079. [Abstract] [Full Text] |
||||






